You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenocarcinoma of the stomach

Showing 1 - 25 of 3,877
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Advanced Gastric Adenocarcinoma Trial in Henan (camrelizumab)

Recruiting
  • Advanced Gastric Adenocarcinoma
  • Henan, China
    Henan Tumor Hospital
Oct 13, 2022

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)

Active, not recruiting
  • Stomach Neoplasms
  • Shanghai, China
    Renji Hospital
Apr 3, 2023

Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)

Recruiting
  • Adenocarcinoma of Stomach
  • Gentuximab Injection
  • Gentuximab Injection Placebo
  • Shanghai, Shanghai, China
    Shanghai Dongfang Hospital
Jun 16, 2023

Stomach Tumors Trial in Wuhan (Fruquintinib, Sintilimab)

Not yet recruiting
  • Stomach Neoplasms
  • Wuhan, Hubei, China
    Wuhan Union Hospital, China
Nov 22, 2022

Colorectal Tumors, NSCLC, Stomach Tumors Trial (SGN-CEACAM5C)

Not yet recruiting
  • Colorectal Neoplasms
  • +5 more
  • (no location specified)
Nov 9, 2023

Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Epstein-Barr Virus-Associated Gastric Carcinoma Trial

Not yet recruiting
  • Adenocarcinoma of the Stomach
  • +2 more
  • Hangzhou, Zhejiang, China
  • +7 more
Jul 25, 2023

Esophagogastric Junctional Adenocarcinoma:A Single Center,

Not yet recruiting
  • Stomach Neoplasms
  • An Intelligent Endoscopic Diagnosis System Developed and Verified Based on Deep Learning
  • (no location specified)
Apr 6, 2023

Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

Not yet recruiting
  • Gastric Cancer
  • S-1, Oxaliplatin, Cadonilimab
  • (no location specified)
Jul 10, 2023

A Recurrence Nomogram for Hepatoid Adenocarcinoma of the Stomach

Completed
  • Gastric Cancer
    • Fuzhou, Fujian, China
      Fujian Medical University Union Hospital
    Mar 9, 2022

    Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

    Not yet recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • TRK-950
    • +2 more
    • Chuo Ku, Japan
      Osaka International Cancer Institute
    Sep 14, 2023

    Gastric Cancer, Gastroesophageal-junction Cancer Trial (IBI315, Oxaliplatin, Capecitabine)

    Not yet recruiting
    • Gastric Cancer
    • Gastroesophageal-junction Cancer
    • (no location specified)
    Nov 2, 2022

    Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (XELOX combined with Fruquintinib and Sintilimab)

    Not yet recruiting
    • Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
    • XELOX combined with Fruquintinib and Sintilimab
    • (no location specified)
    Oct 17, 2023

    Gastric Cancer, GastroEsophageal Cancer, Fruquintinib Trial in Nanning (Fruquintinib + SOX)

    Recruiting
    • Gastric Cancer
    • +3 more
    • Fruquintinib + SOX
    • Nanning, China
      Guangxi Medical University Cancer Hospital
    Dec 2, 2022

    Advanced Gastric Cancer Trial in Shanghai (Transcatheter Arterial Chemoembolization, Tislelizumab)

    Recruiting
    • Advanced Gastric Cancer
    • Shanghai, Shanghai, China
      ZhongShan hospital Fudan university
    May 25, 2022

    HER2-positive Advanced Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma Trial (Trastuzumab deruxtecan)

    Not yet recruiting
    • HER2-positive Advanced Gastric Cancer
    • HER2-positive Gastroesophageal Junction Adenocarcinoma
    • Trastuzumab deruxtecan
    • (no location specified)
    Aug 11, 2023

    Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair Trial in China (S1,

    Not yet recruiting
    • Adenocarcinoma of the Stomach
    • +2 more
    • Hangzhou, Zhejiang, China
    • +4 more
    May 23, 2023

    HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

    Not yet recruiting
    • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
    • SHR-A1811
    • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
    • (no location specified)
    Nov 6, 2023

    Stomach Tumor Trial in Chengdu (Capeox regimen combined with Sintilimab and Bevacizumab)

    Not yet recruiting
    • Stomach Neoplasm
    • Capeox regimen combined with Sintilimab and Bevacizumab
    • Chengdu, China
      Liu Ming
    Nov 28, 2022

    HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811;SHR-1701;capecitabine;oxaliplatin)

    Not yet recruiting
    • HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
    • (no location specified)
    Jan 3, 2023

    Gastric Adenocarcinoma, Esophagogastric Junction, Gastric Cancer Trial run by the National Cancer Institute (NCI) (Surgery,

    Recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • Surgery
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Gastric Cancer Trial

    Completed
    • Gastric Cancer
      • (no location specified)
      Dec 20, 2022

      Gastric Cancer Trial (Fruquintinib)

      Not yet recruiting
      • Gastric Cancer
      • (no location specified)
      Oct 17, 2023